The United States potassium thiosulfate fertilizer market is growing steadily, driven by precision agriculture adoption, demand for efficient nutrient delivery, and expanding high value crop production through 2031.

The Pharma ADMET Testing Market is growing at a 10.49% CAGR during 2026–2034, driven by rising late-stage drug failures, stricter regulations, early safety screening demand, and adoption of AI and in vitro testing.

The patient-derived xenograft model market is set to grow at a 13.5 percent CAGR from 2025 to 2031, driven by precision oncology, translational research, rising cancer cases, and increasing adoption of predictive preclinical models.